State Of Wyoming Abb Vie Inc. Transaction History

State Of Wyoming

$587 Million
Q1 2024

A detailed history of State Of Wyoming transactions in Abb Vie Inc. stock. As of the latest transaction made, State Of Wyoming holds 998 shares of ABBV stock, worth $171,176. This represents 0.03% of its overall portfolio holdings.

Number of Shares

998

Previous 5,159 80.66%

Holding current value

$171,176

Previous $799,000 77.35%

% of portfolio

0.03%

Previous 0.15%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $665,011 - $757,718	-4,161 Reduced 80.66%	998 $181,000
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $37,564 - $42,306	273 Added 5.59%	5,159 $799,000
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $223,362 - $258,574	1,672 Added 52.02%	4,886 $728,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $11,395 - $14,181	-86 Reduced 2.61%	3,214 $433,000
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $6,073 - $6,994	-42 Reduced 1.26%	3,300 $525,000

Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $352,275 - $422,470	-2,547 Reduced 43.25%	3,342 $540,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $452,958 - $519,513	3,375 Added 134.25%	5,889 $790,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $345,976 - $439,849	2,514 New	2,514 $385,000
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $241,259 - $299,335	-1,828 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $130,205 - $164,747	1,212 Added 196.75%	1,828 $248,000
Q3 2021 Feb 14, 2022	BUY	$106.4 - $120.78 $65,542 - $74,400	616 New	616 $66,000
Q2 2021 Feb 11, 2022	SELL	$105.21 - $117.21 $178,436 - $198,788	-1,696 Closed	0 $0
Q1 2021 Feb 08, 2022	BUY	$102.3 - $112.62 $173,500 - $191,003	1,696 New	1,696 $184,000

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account